STOCK TITAN

First shoulder arthroplasty surgeries using Stryker’s Blueprint® Mixed Reality Guidance System completed in Europe

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
Stryker (SYK) introduces Blueprint Mixed Reality Guidance System for shoulder arthroplasty surgeries in Europe, enhancing precision and customization for surgeons.
Positive
  • None.
Negative
  • None.

The introduction of Stryker's Blueprint Mixed Reality (MR) Guidance System represents a significant advancement in the field of orthopaedic surgery, particularly for shoulder arthroplasty. This system, which integrates Stryker's software with the Microsoft HoloLens 2 headset, could potentially lead to improved surgical outcomes through enhanced precision and personalization of the surgical process. By allowing surgeons to visualize 3D images and guidance widgets directly in their line of sight, the technology promises to streamline the surgical workflow and reduce the likelihood of errors.

From an industry perspective, the adoption of such technology could set a new standard for pre-operative planning and intraoperative navigation. Given that the system has received a CE mark, indicating conformity with health, safety and environmental protection standards for products sold within the European Economic Area, it is poised for broader adoption in Europe. This could lead to increased market demand for Stryker's products, potentially impacting the company's financial performance positively if the technology is widely accepted and adopted.

Considering the broader market implications, the successful implementation of the Blueprint MR Guidance System in Europe could serve as a catalyst for Stryker's market share growth in the medical technology sector. The company's strategic collaboration with surgeons and integration with Microsoft's advanced technology indicates a commitment to innovation, which is crucial for maintaining competitive advantage in the fast-evolving medtech industry.

Investors should monitor the outcomes of the pilot study being conducted in France, as positive results could lead to increased trust and credibility among surgeons, potentially driving further adoption. The long-term success of this technology will depend on its ability to demonstrate tangible benefits over traditional surgical methods, such as reduced operation times, lower complication rates and quicker patient recovery times, which would ultimately translate into cost savings for healthcare providers.

Financially, the launch of a new product like the Blueprint MR Guidance System could have a notable impact on Stryker's revenue streams. The medical device sector is known for high barriers to entry due to stringent regulatory requirements and significant R&D expenditures. However, once these barriers are overcome, the introduction of innovative products can lead to substantial returns on investment. The fact that the system has already been used in the U.S. and Canada and now in Europe, suggests that Stryker is effectively expanding its global footprint.

It is essential to evaluate how the adoption of this technology will affect operating costs and whether it will require additional investment in training or support infrastructure. Investors should also consider the potential for this technology to create recurring revenue through software updates, disposable components, or service contracts, which could contribute to a more stable and predictable revenue stream for Stryker.

Blueprint Mixed Reality Guidance System offers shoulder arthroplasty surgeons a new tool to execute their pre-operative plan

AMSTERDAM--(BUSINESS WIRE)-- Stryker (NYSE:SYK), a global leader in medical technologies, today announced that the first shoulder arthroplasty surgeries using Blueprint Mixed Reality (MR) Guidance in Europe have been successfully completed by Professor Julien Berhouet, MD, PhD, CHRU Tours Hospital, France, and Dr. Lionel Neyton, MD, orthopaedic shoulder surgeon at Centre Orthopédique Santy and Hôpital Privé Jean Mermoz in Lyon, France.

Stryker's Blueprint Mixed Reality Guidance System offers shoulder arthroplasty surgeons a new tool to execute their pre-operative plan. (Photo: Business Wire)

Stryker's Blueprint Mixed Reality Guidance System offers shoulder arthroplasty surgeons a new tool to execute their pre-operative plan. (Photo: Business Wire)

“It’s exciting to be one of the first two hospitals in Europe to use Stryker’s Mixed Reality Guidance System,” said Professor Berhouet. “I am also pleased to be leading a pilot study to investigate the safety and effectiveness of this new technology, alongside three other centres in France.”

“The Blueprint Mixed Reality System allows me to tailor my shoulder joint replacement procedures to the unique needs and anatomy of my patients,” Dr. Neyton added.

Designed in collaboration with a team of world-class surgeons, the Blueprint Mixed Reality Guidance System combines Stryker's innovative software with the Microsoft HoloLens 2 headset, allowing the surgeon to track the position and orientation of surgical instrumentation in the physical environment. Blueprint Mixed Reality Guidance System allows surgeons and their instruments to be ‘guided’ by 3D images and guidance widgets, which can be displayed on the patient and in the surgeon’s line of sight without disrupting normal workflow. The MR Guidance system received a CE mark at the end of 2023 and the first surgeries globally were performed in the U.S. and Canada in December 2023.

“This latest tool builds upon a decade of Blueprint's presence in Europe, and we continue innovating to ensure the platform has the potential to further benefit surgeons and patients alike,” said Markus Ochs, vice president and general manager of Stryker’s European Trauma & Extremities division.

To learn more about Blueprint and Mixed Reality, visit stryker.com.

About Stryker

Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.

_____________________

Dr. Lionel Neyton and Professor Berhouet are paid consultants of Stryker Trauma and Extremities. The opinions expressed by Dr. Lionel Neyton and Professor Berhouet are those of Dr. Lionel Neyton and Professor Berhouet and not necessarily those of Stryker. Individual experiences may vary.

A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any product before using it in surgery.

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.

Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Blueprint, Stryker. Microsoft and HoloLens are trademarks of the Microsoft group of companies. All other trademarks are trademarks of their respective owners or holders.

Content ID: AP-017235
Copyright © 2024 Stryker

Sampson Public Relations Group

Andrea Sampson

President/CEO

asampson@sampsonprgroup.com

Source: Stryker

FAQ

What is the latest technology introduced by Stryker for shoulder arthroplasty surgeries in Europe?

Stryker has introduced the Blueprint Mixed Reality Guidance System for shoulder arthroplasty surgeries in Europe.

Who successfully completed the first shoulder arthroplasty surgeries using Blueprint Mixed Reality Guidance in Europe?

Professor Julien Berhouet, MD, PhD, CHRU Tours Hospital, France, and Dr. Lionel Neyton, MD, orthopaedic shoulder surgeon at Centre Orthopédique Santy and Hôpital Privé Jean Mermoz in Lyon, France.

What is the key feature of Stryker's Blueprint Mixed Reality Guidance System?

The system combines innovative software with the Microsoft HoloLens 2 headset to track the position and orientation of surgical instrumentation in the physical environment.

When did the MR Guidance system receive a CE mark?

The MR Guidance system received a CE mark at the end of 2023.

Where were the first surgeries using the MR Guidance system performed globally?

The first surgeries globally were performed in the U.S. and Canada in December 2023.

Stryker Corporation

NYSE:SYK

SYK Rankings

SYK Latest News

SYK Stock Data

125.12B
340.60M
5.39%
78.85%
1.12%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
KALAMAZOO

About SYK

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.